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1 
General Introduction 
Ras proteins 
The scientific community was first introduced to Ras in 1964. Jennifer Harvey 
reported that sarcomas formed in new born rodents after exposure to murine leukemogenic 
virus plasma taken from a leukemic rat [1], It was found later that the properties that induced 
the tumor formation was actually part of the rat genome. The gene and its protein product 
were named H-Ras (Harvey rat sarcoma) after the discoverer and origin [2], In later years, 
the Kirsten (K-Ras) and neuroblastoma (N-Ras) isoforms of Ras were discovered [3-5]. 
Ultimately, the Ras genes were isolated from human cancer cells [6-8]. A mutated form of 
Ras has been implicated in 35% of lung tumors, 40% of colon tumors, 60% of thyroid tumors 
and 90% of pancreatic cancers [9], 
Four different isoforms of Ras are encoded in the human genome: H-Ras, N-Ras, K-
Ras 4A and K-Ras 4B. K-Ras 4B is universally expressed and K-Ras 4A is the alternatively 
spliced isoform [10]. The four Ras isoforms are highly homologous in amino acid sequence. 
All four isoforms of Ras are 100% conserved in the first 86 residues and 79% conserved in 
residues 86-164. The Ras isoforms depart in sequence conservation in the 25 C-terminus 
amino acids also known as the hypervariable domain. All Ras isoforms have a CAAX box 
motif at the C-terminus where C is cysteine, A is an aliphatic amino acid and X is any amino 
acid. The CAAX box motif is responsible for initiating the post-translational modifications 
that occur on all Ras proteins [10, 11]. 
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Ras the GTPase 
Ras is a 21kDa monomelic GTPase that cycles between the active GTP state and 
inactive GDP state. The intrinsic GTPase activity of Ras is very poor, hydrolyzing GTP at a 
rate of about lO'V1. The GTPase activity is accelerated 105 fold by the GTPase activating 
protein (GAP). Because the level of GTP in the cell is nearly 10 times that of GDP, Ras will 
naturally be bound to GTP. In order to accelerate the exchange of GDP for GTP, guanine 
nucleotide exchange factor (GET), is required to dissociate the GDP. The three structural 
regions involved in GTPase activity are: the P-Loop, switch 1 and switch 2. The amino acid 
mutations of G12V and Q61L occur in the P-Loop and switch 2 regions, respectively. It is 
these mutations that hinder the GTPase acitivity and incur upon Ras its oncogenic properties 
[12]. 
Ras effectors 
When Ras is bound to GTP it is able to associate with its effectors. The most studied 
pathway to date has been the mitogen-activated protein kinase/extracellular regulated kinase 
(MAPK/Erk) cascade. The MAPK, p42 and p44, are known as Erkl and Erk2 respectively 
and are so similar that they are considered nearly functionally identical [13]. The main 
components of the MAPK cascade consist of Raf-1, MAP/Erk kinase (MEK) and Erkl/2. 
The GTP bound Ras protein binds Raf-1 via its Ras binding domain (RBD). Raf-1, a 
serine/threonine kinase, then phosphorylates and activates MEK. MEK, a dual specificity 
tyrosine/threonine kinase, phosphorylates and activates Erkl and Erk2. Erkl and Erk2 are 
serine/threonine kinases that form dimers when phosphorylated and translocate to the nucleus 
where they phosphorylate the Ets family of transcription factors [14]. Recently, the scaffold 
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protein kinase suppressor of Ras-1 (KSR-1) was demonstrated to be an important part of 
MAPK signaling. KSR-1 is able to bind Raf-1, MEK and Erk enabling a more controlled 
signal simply by having all of the effectors in the same area. More importantly, the scaffold 
protein, similar expression to FGF (fibroblast growth factor) genes (Sef), was found bound to 
MEK and Erk on the Golgi [15]. This added to the growing list of evidence supporting the 
importance of signal transduction from the Golgi. 
Three other well characterized effectors of Ras are MEKK, phosphatidyl inositol-3-
kinase (PI3K) and Ral GEFs. The MEKK are involved in the phosphorylation c-Jun N-
terminal kinase (INK) which lead to the phosphorylation of the c-Jun transcription factor 
[16]. PI3K phosphorylates Akt, otherwise known as protein kinase b (PKB), which mediates 
antiapoptotic signals. PI3K also links the Ras pathway to Rho/Rac proteins by a mechanism 
that has yet been elucidated [17]. The Ral GEFs interact with Ral GTPases, a relative of Ras 
that is involved in activating phospholipase Dl. Some of the Ral GEFs are: Ral-GO S, RLF 
and Rgl [18]. A recent report has implicated Ral GO S in having a role in human 
oncogenesis[19], 
Posttranslational processing 
Ras begins its life in the cell by being translated on free ribosomes in the cytosol. 
The C-terminal CAAX box motif is then recognized by famesyl transferase (FTPase) where 
it binds Ras with nanomolar affinity. The FTPase then attaches a 15 carbon isoprenoid, 
famesyl diphosphate, to the cysteine of the CAAX box motif via a very stable thioether bond 
[20]. With a lipid tethered to the C-terminus, Ras becomes a substrate for Ras and a-factor 
converting enzyme (Reel) a protein that resides in the ER membrane and cleaves the A AX 
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amino acids from the C-terminus of Ras [21]. Ras then proceeds to the next enzyme, 
isoprenylcysteine carboxyl methyltransferase (Icmt), where the a-carboxyl group on the 
isoprenylated cysteine is methylated with S-adenosylmethione donating the methyl 
group[22], At this point the different Ras isoforms diverge. K-Ras,with its polylysine 
sequence in the HVR, does not require further processing and proceeds to the plasma 
membrane (PM) via an uncharacterized mechansim[23]. N-Ras and H-Ras are further 
modified by Ras palmitoyltransferase (RPT) which attaches a palmitoyl from palmitoyl-CoA 
to C181 on N-Ras and CI81 and CI84 on H-Ras via a labile thioester bond. Recently the 
mammalian RPT complex, DHHC9 (Asp-His-His-Cys motif) and GCP16 (Golgi localized 
protein), was identified as a palmitoyl transferase for H-Ras and N-Ras. 
Immunofluorescence analysis indicated that this complex resides in the ER and the Golgi 
[24]. Recent studies report evidence of an acylation cycle that shuffles a depalmitoylated 
Ras to the Golgi to be repalmitoylated. This substantiates a mechanism of Ras 
palmitoylation on the Golgi [25, 26]. 
Ras signaling from endosomes 
Since its discovery, it was believed that Ras needs to be at the PM to signal. This 
paradigm was put into question in 1994. It was demonstrated that, after administering a large 
dose of epidermal growth factor (EGF) to rat parenchyma, the Ras effectors She, Grb2 and 
mSOS were isolated on early endosomes [27]. This discovery fostered the idea that 
epidermal growth factor receptor (EGFR) signaling may continue while the EFGR is on 
endosomes. 
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The next step came through the utilization of the K44A dominant negative mutation 
of dynamin. Dynamin is a GTPase that regulates clathrin mediated endocytosis and the 
K44A mutation prevents endocytosis. It was found that MAP kinase activity was suppressed 
in endocytosis deficient cells containing K44A dynamin. The p85 subunit of PI3 kinase also 
showed a greatly reduced phosphorylation. These data lead to the conclusion that EGFR 
trafficking via endosomes was important to promote downstream signaling events[28], 
There is direct evidence that Ras is bound to endosomes. Ras was found on purified 
endosomal fractions separated from rat liver [29]. Specific Ras isoform targeting to 
endosomes was elucidated by Jiang and Sorkin. Both H-Ras and K-Ras were found on 
endosomes together with their effector proteins using fusion protein based technology and 
fluorescence resonance energy transfer (FRET). Interestingly, the relative amount of H-Ras 
was higher than K-Ras on endosomes and GTP loading was not a factor. The most important 
tool employed was the Ras binding domain(RBD) of Raf-1 fused to YFP. Since the RBD 
only binds a Ras protein that is GTP loaded, the YFP-RBD was a valuable tool to gauge 
whether Ras was active in a cellular environment [30]. 
Because the antibody probe used in the Pol experiment was not specific to H-Ras the 
question remained which Ras isoform was on endosomes. Hancock's group used the 
dynamin K44A mutant along with GFP fusion proteins of H-Ras and K-Ras to demonstrate 
that H-Ras and not K-Ras was dependant upon endosomal traffic in order to propagate its 
signal through the Raf/MEK/MAPK cascade. Unlike previous experiments that looked at 
EGFR stimulation, Hancock used the G12V constitutively active form of Ras to initiate Raf 
binding to Ras[31], The scientific community was now fairly convinced that Ras could not 
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only signal from a platform other than the PM, but the H-Ras isoform actually required 
endosomes to relay its signal through at least one of the known cascades. 
Ras signaling on the ER 
The C181,C184S double mutant of H-Ras is palmitoylation deficient and is limited to 
the ER and cytosol[23]. The first transmembrane domain of the avian infectious bronchitis 
virus M protein (Ml) has also been shown to be restricted to the ER because of its 
transmembrane sequence [32]. H-Ras61L was fused to the C-terminus of the Ml protein and 
it, as well as, the 61L version of the C181S, C184S double mutant were transfected into NIH-
3T3cells and stained for focus formation. Both constructs were found to have approximately 
60% of the transformng activity as H-Ras 61L transfected cells. This was a strong indication 
of biological activity of H-Ras on the ER. Phosphorylation levels of proteins in Ras signal 
cascades were also measured from COS cells transiently transfected with H-Ras61L 
containing the ER localized mutations. The percent of H-Ras61L induced phosphorylation 
of phospho-Akt, Erk and Jnk was lower in the ER localized mutants than in H-Ras61LWT 
(H-Ras with only the Q61L mutation) but higher than vector alone. Interestingly,in the Ml 
mutant, the phospho-Jnk activation was greater than H-Ras61LWT or the C181S,C184S 
construct [33]. This data seems to point to a difference in signaling capability when H-Ras is 
in its natural membrane orientation, C181S, C184S mutant, versus an N-terminal tether, Ml, 
where the orientation of H-Ras in regards to the membrane may be completely different. 
In order to test whether H-Ras could be GTP loaded while residing on the ER, COS-7 
cells were transiently transfected with H-Ras and stimulated with either ionomycin or 
lysophosphatide acid (LPA) and imaged. It was found that the Ras GEFs, RasGRFl and 2, 
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both colocalized with H-Ras, indicating GTP loading. GTP loading was also confirmed 
with the Ml tether and C181S,C184S mutant [34]. 
These sets of experiments demonstrated that both a constitutively active, as well as, a 
signal activated H-Ras can signal from the ER. 
H-Ras signaling from the Golgi Apparatus 
With strong evidence for H-Ras signaling from both endosomes and the ER, 
researchers asked whether Ras could signal from the Golgi. H-Ras and N-Ras had both been 
shown to accumulate in the Golgi, so the idea of the Golgi as signaling platform was 
plausible [35]. 
Golgi localized H-RasWT and H-Ras61L activity was shown in COS-1 cells. First, 
the cells were cotransfected with H-RasWT and GFP-RBD and stimulated with EGF. There 
was a distinct difference in GFP-RBD recruitment to the Golgi versus the PM. The PM 
recruitment was rapid, within 1-3 minutes, with a peak at 10 minutes. The Golgi recruitment 
was delayed, occured in 10 minutes, with continued accumulation to 60 minutes. Next 
phosphorylation levels of downstream effectors were compared in cells expressing either H-
RasôlLWT and KDELr-H-Ras61LWT. The KDEL receptor (KDELr) is a resident protein in 
the Golgi that traffics back to the ER. An N193D mutation in KDELr keeps it in the Golgi. 
KDELr was tethered to the N-terminus of H-Ras61L. The levels of phosphorylation for the 
cells expressing the KDELr-H-Ras61L construct were greater in phospho-Akt and Erk when 
compared to cells expressing H-Ras61LWT. Phosphorylation levels of phospho-Jnk in the 
KDELr-H-Ras61L cells were, however, much lower than the H-Ras61LWT cells [33]. These 
assays established the ability of H-Ras to signal from the Golgi. 
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H-Ras was shown to have a GEF specific to the Golgi in PC12, COS-1 and Jurkat 
cells. Phospholipase Cyl (PLCyl) was activated in a calcium-dependant manner that 
recruited RasGRPl,a Ras GEF, to the Golgi upon stimulation [36]. With the confirmation of 
a Golgi specific GEF for Ras, it seemed clear that Ras could signal from the Golgi in its 
natural state. Recently, it was reported that a Ras effector, Ras interacting protein (Rain), 
was Golgi specific [37]. 
All assays to this point were done with transiently transfected cells, the next step was 
to use a stable cell line. NIH-3T3 stable cell lines were created with various membrane site-
specific proteins fused to H-RasG12V, one of which was the KDELr. Although KDELr-H-
RasV12 bound to RBD-GST in vitro, colocalization with endogenous c-Raf in vivo was 
limited. The phophorylation levels of phospho-Akt and Erk were diminished in the KDELr-
H-RasV12 cells compared to the H-RasVI2 cells. Phospho-Jnk and GTP loaded Ral were 
both comparable in each cell type [38]. As with the Ml constructs on the ER, there seemed 
to be a distinct preference for signaling pathways from the Golgi. 
Trafficking of C-terminal mutations in H-Ras 
The C-terminus of each of the Ras isoforms is unique and it is this difference that aids 
in targeting each to a specific pathway and preferred compartment. Single point mutations 
that remove one or both of the palmitoylation sites give insights into a possible preference in 
the C-terminus orientation with a membrane, or the lifetime of the Ras molecule on a 
particular membrane. If there is a C181S mutation, leaving only the CI 84 palmitoylated, H-
Ras will accumulate on the Golgi with very little reaching the PM. The C184S H-Ras 
protein is much more prevalent on the PM with some Golgi and ER accumulation as well. 
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Notably, both mutations are equally more soluble than the wild type H-Ras, with 
approximately 50% of each total protein being in the soluble fraction of the cell lysates. 
Cells treated with [3H]palmitic acid were lysed and blotted and demonstrated that each 
mutant did indeed have a palmitate [39]. 
A C-terminus mutation of H-Ras created by Buss and colleagues changed the wild 
type GCMSCKCLVS to GSDQCECVLS (SDQ). The removal of the lysine and addition of 
glutamate and aspartate changes the overall charge on the C-terminus from +1 to -2, as well 
as, removing the site for 181 palmitate attachment. The work of this thesis shows that this 
protein has strong Golgi accumulation with none of the protein reaching the PM. As with the 
C181S and C184S mutations, the SDQ mutation renders the H-Ras protein much more 
soluble than the wild type. Though SDQ transformation was almost zero, activity could be 
restored by adding a leader sequence to the N-terminus that encoded a myritoylation site. 
This indicated that the protein was in the correct conformation and could bind its effectors. 
[3H] palmitic acid labeling was also performed and illustrated that the SDQ mutant was 
palmitoylated [40]. The SDQ mutant therefore seems to be an excellent tool for studying H-
Ras signaling from the Golgi. 
Purpose of the SDQ mutant and this thesis 
By studying signaling of the SDQ mutant we hope to ascertain a truer sense of 
cascades that originate from the Golgi. We believe that SDQ H-Ras presents a more natural 
orientation of the molecule in the cell. Whereas SDQ has been shown to be palmitoylated 
and is, therefore, most probably tethered to the membrane via its lipids, the KDELr-H-Ras 
fusion protein with its N-terminus tethered to a membrane cannot be assured to have the 
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same natural orientation. Indeed, the KDELr-H-RasV12 mutants showed a lack of 
biological activity when they were stained for focus formation [38]. Despite the fact that 
Willumsen was unable to show biological activity with the SDQ61L mutant, the more recent 
work, with the mutant expressing from a stronger cDNA vector, showed focus formation at 
about 30% of H-RasWT61L [41]. With the ability to cycle on and off the membrane and a 
more natural membrane orientation, the hypothesis of this thesis is that the SDQ mutation of 
H-Ras seems an excellent candidate for testing signaling from the Golgi. 
List of abbreviations 
GEF-guanine nucleotide exchange factor 
GAP-GTPase activating protein 
RBD-Ras binding domain 
EGF-epidermal growth factor 
PM-plasma membrane 
ERGIC-ER-Golgi intermediate compartment 
GTP-guanine nucleotide triphosphate 
ER-endoplasmic reticulum 
MAPK-mitogen-activated protein kinase 
Erk-extracellular regulated kinase 
JNK-c-Jun N-terminal kinase 
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Materials and Methods 
Plasmids 
H-RasWT and H-RasWT61L were expressed from pcDNA3 (Invitrogen). The 
SDQCE, CDQSE, C181S and C184S mutants were generated oligonucleotide-directed 
polymerase chain reaction (PGR). The 5' primer is5'-GGGGGGATCCACCA TGACAGAA 
TACAAGCTT-3', which is fully complimentary to the 5' sequence of human H-Ras. The 
mutagenic oligonucleotides 5 ' - AT AG AC GT C TT A AGGATTG A ATT AT GCGT A AGT G A A 
ACTAGTGACGGCCCG-3' (CDQSE) and 5'-
ATAGACGTCTTAAGGATTGAATTATGCG TAAGTGAAACTAGTGTCGGCCCCG-31 
(SDQCE) were used as 3' primers for introducing an EcoRI site and Ras carboxyl terminal 
mutants. The mutagenic oligonucleotides 5 -CCTG CAGCTCATGGAGCCGGGGCCACT-
3' (C181S) and 5-GAGCACACACTTGGAGCT CATGCAGCC-3' (C184S) were used as 3' 
primers for site directed mutagenesis via PCR. 
Cell culture and transaction 
NIH3T3 and COS-7 cells were grown in DMEM (GIBCO-Invitrogen) + 10% bovine 
calf serum. All cells were grown in 10% CO? Stable NIH3T3 cells lines were created by 
transfecting (Effectene) a 100mm cell culture dish 70% confluent with NIH3T3 cells with 
1.0 p,g of DNA for 24 hours. Cells were then selected with 750 ug/ml of G418 and protein 
expression was confirmed via immunofluorescence. Briefly, cells from 3 separate 
experiments were grown on coverslips, stained with anti-H-Ras antibody, mounted on glass 
slides and imaged with a Leica DMIRE2 fluorescent microscope. 100 cells were counted on 
each coverslip and each cell expressing an H-Ras construct was scored. The standard 
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deviation of the 3 separate cells counts was calculated and the SEM reported. Student T-
test compared the values of wild type cells versus either the SDQ or CDQ cells. COS-7 cells 
were plated 24 hours prior to transient transfection (Effectene)in a 12 well tissue culture plate 
at a density of about 105-106 cells per well and transfected as described by the Effectene 
protocol. NIH3T3 and COS-7 cells were plated on pre-washed coverslips (Corning) coated 
with poly-L-lysine (100 ^g/ml) and fibronectin ( 50 ^g/ml). 
Immunofluorescent images 
COS-7 cells were cultured and transfected as described above. NIH-3T3 cells stably 
expressing H-RasWT, CDQSE and SDQCE were grown on coverslips for 24 hours prior to 
being treated with 40 ng/ml of EGF for either 5, 30 or 60 minutes. The cells were washed in 
PBS twice and fixed with 4% paraformaldehyde in PBS 30 minutes at room temperature. 
The cells were permeablized with -20°C methanol for 30 seconds and quenched with 50mM 
NH4C1 in PBS for 15 minutes at room temperature. Cells were then blocked with blocking 
buffer (0.4% BSA and 2% horse serum in PBS) for 1 hour at room temperature. Cells were 
then incubated in primary antibody diluted in blocking buffer for 1 hour at room temperature, 
rinsed 3 times in TTBS and incubated in secondary antibody another hour at room 
temperature . Cells were then washed in PBS and distilled water and mounted on a glass 
slide with mounting media (Vectashield) and adhered with regular nail polish. Untransfected 
cells were stained as a negative control. Each set of experiments was repeated 3 times. 
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Antibodies 
Ab Ig 
Class 
Immunogen Application Concentra 
tion 
Source Company 
Ras 238 IgG2a Human H-
Ras 
Immunofluo 
rescence(IF) 
0.4 ^ig/ml Rat 
monoclonal 
Santa Cruz 
Giantin IgGl Human 
Giantin 
IF 1:400 Rabbit 
polyclonal 
Covance 
ERGIC-53 IgGl Human 
ERGIC-53 
IF 5 ^ig/ml Mouse 
monoclonal 
Axxora 
Raf-1 IgGl Human Raf-
1 
IF 1 ng/ml Rabbit 
polyclonal 
Santa Cruz 
Alexafluor IgG Rat IgG IF 2 ^ig/ml Donkey Molecular 
488 Probes 
Alexafluor IgG Rabbit IgG IF 2 ^ig/ml Goat Molecular 
594 Probes 
Alexafluor IgG Mouse IgG IF 2 ^ig/ml Goat Molecular 
594 Probes 
Alexafluor IgG Rabbit IgG IF 2 ^ig/ml Goat Molecular 
555 Probes 
Alexafluor IgG Mouse IgG IF 2 ^ig/ml Goat Molecular 
647 Probes 
Pan Ras IgGl Human H- Western 0.5 ^ig/ml Mouse BD Trans. 
Ras Blot (WB) monoclonal Laboratories 
Caveolin-1 IgGl Human 
Caveolin-1 
WB 0.25 ^g/ml Rabbit 
polyclonal 
BD Trans. 
Laboratories 
Pi-Erk IgGl Synthetic 
Phospho-
peptide of 
Human 
Erk(Thr 
202/Tyr 
204) 
WB 1:1000 Mouse 
monoclonal 
Cell 
Signaling 
Erkl IgGl Rat Erkl WB 0.1 ^ig/ml Rabbit 
polyclonal 
Santa Cruz 
Pi- IgGl Synthetic WB 1:1000 Mounse Cell 
SAPK/JNK phospho-
peptide of 
Human 
JNK(Thr 
183/Tyr 
185) 
monoclonal Signaling 
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Ab Ig 
class 
Immunogen Application Concentra 
tion 
Source Company 
SAPK/JNK IgGl Human 
JNK2/MBP 
fusion 
protein 
WB 1:1000 Rabbit 
monoclonal 
Cell 
Signaling 
Pi-Akt IgGl Synthetic 
phospho-
peptide of 
Mouse 
Akt(Ser 
473) 
WB 1:1000 Rabbit 
polyclonal 
New 
England 
Biolabs 
Akt IgGl Sythetic 
peptide of 
Mouse 
Akt(466-
479) 
WB 1:1000 Rabbit 
polyclonal 
New 
England 
Biolabs 
GaM HRP IgG Mouse IgG WB 0.08 ^g/ml Goat Pierce 
Secondary 
Ab 
GaRHRP IgG Rabbit IgG WB 0.08 ^g/ml Goat Pierce 
Secondary 
Ab 
Imaging 
Cells were imaged with a lOOx oil lense on a Leica DM IRE2 inverted fluorescent 
microscope. Images were captured with a Q Imaging Retiga 1300 camera, processed with 
Openlab 3.1.4 and converted to JPEG files with Adobe Photoshop 7.0. X-ray films of 
western blots were scanned with an HP 2300 series scanner/printer and denisometry was 
carried out with ImageJ. 
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Immunoblots 
NIH-3T3 cells were cultured in 100mm tissue culture plates and treated with 40 
ng/ml EGF for either 10, 30 or 60 minutes. Cells were lysed with 1.0 ml of lysis buffer (150 
mM NaCl, 20 mM Tris-HCl pH 7.5, 20 mM MgCl and 0.5% NP-40) on ice and 5X SDS-
PAGE loading buffer (10% SDS, 400mM Tris pH 6.8, 500 mM DTT, 10% glycerol, 
Bromophenol blue 0.04%) was added immediately. Samples were boiled for 10 minutes and 
proteins were separated by SOS-PAGE Proteins were transferred by electrophoration to a 
PVDF membrane and blocked with 5% milk in TTBS at room temperature for 1 hour. 
Membranes were then probed with primary antibody overnight at 4°C, rinsed 3 times in 
TTBS and probed in secondary HRP conjugates for 1 hour at room temperature. Membranes 
were then rinsed 3 times in TTBS and developed with SuperSignal according to the 
manufacturer's protocol (Pierce). 
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Results 
H-RasSDQCE is trapped on ERGIC and cis-Golgi 
Studies have demonstrated that H-RasWT, H-RasC 181S and H-RasC184S accumulate 
in a perinuclear region. In order to discern which organelle demonstrates H-Ras 
accumulation, COS-7 cells were transfected with either H-RasWT, C181S, C184S, SDQCE 
or CDQSE for 24 hours, fixed and stained with H-Ras antibody and either ERGIC-53 or 
giantin. The ER Golgi intermediate compartment (ERGIC) is an organelle that exists 
between the ER and the cis-Golgi. H-RasWT, CI8IS, C184S and SDQCE all showed some 
colocalization with ERGIC-53 (Figure 1). CDQSE, however, had very limited colocalization 
with ERGIC-53. Since complete colocalization of the H-Ras proteins with ERGIC-53 was 
not observed there was the possibility that H-Ras was accumulating on the cis-Golgi as well 
as the ERGIC. H-RasWT, C181S, C184S and SDQCE all were colocalized to some extent 
with giantin (Figure 2). Once again CDQSE colocalized very little with giantin. It seems that 
H-RasWT, C181S, C184S and SDQCE accumulates on both the ERGIC and Golgi, however 
CDQSE did not. 
The SDQCE transfected cells did not display any PM decoration by this Ras 
construct. H-RasWT, C184S and, to a lesser extent, C181S expressing cells did show Ras 
accumulation at the PM. The CDQSE expressing cells showed a strong perinuclear and ER 
staining. SDQ is lacking a potential palmitoylation site like CI8IS, but is unable to reach the 
PM. SDQ has the same amino acid charge change like CDQSE, but it is able to accumulate 
in the ERGIC/cis-Golgi unlike the ER localization of CDQSE. The combination charge 
17 
change due to amino acid mutation and lack of palmitoylation site at C181 has incurred 
upon SDQ its unique qualities of Golgi localization without PM localization. 
H-RasSDQCE can be GTP loaded on the Golgi after EGF stimulation 
The next test was to determine whether SDQ could be GTP loaded on the Golgi. 
NIH-3T3 cells stably expressing either SDQ, CDQSE or H-RasWT were stimulated with 40 
ng/ml of EGF for either 5, 30 or 60 minutes. The cells were fixed and stained with H-Ras 
and Raf-1 antibodies to determine if endogenous Raf-1 would colocalized with H-Ras upon 
stimulation. 
H-RasWT showed colocalization with Raf-1 at the PM at both 5 minutes and 30 
minutes of stimulation (Figure 3B and 3C). H-RasWT also colocalizes with Raf-1 on 
endosomes (Figure 3B,C and D). Endosomal colocalization begins at 5 minutes and 
predominates over PM colocalization by 60 minutes. 
CDQSE was unable to demonstrate any significant colocalization with Raf-1 upon 
stimulation (Figure 4). By 60 minutes of stimulation a few areas of weak colocalization are 
evident (Figure 4D). CDQSE does not appear to have the ability to be GTP loaded via the 
EGF pathway or cannot interact with Raf-1 from its ER membrane location. 
SDQ shows strong colocalization with Raf-1 after 30 minutes of stimulation (Figure 
5). After 5 minutes of stimulation SDQ does not colocalize with Raf-1 (Figure 5B). Strong 
colocalization of SDQ with Raf-1 is evident after 30 minutes of stimulation with very strong 
colocalization apparent at the 60 minute mark (Figure 5C and D). H-Ras is thus able to be 
GTP loaded on the Golgi via EGF stimulation and can interact with Raf-1 at this location. 
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Stable cells were counted and percentage of cells expressing H-RasWT, SDQCE or 
CDQSE was determined (Figure 6). The number of cells expressing H-RasWT or SDQCE 
(T-test; P<0.1) and H-RasWT or CDQSE (T-test;P<0.01) were found to be significantly 
different. The lower percentage of cells expressing H-RasWT versus either SDQCE or 
CDQSE may be due to the different C-termini which may effect the lifetime of the protein in 
the cell. 
SDQ elicits a delayed signal cascade on the Golgi 
Previous reports had demonstrated the activation of downstream phophorylation 
signals in cells expressing a Golgi localized H-Ras constitutively active, Q61L or G12V, 
construct. This observation was evident for three of the common signaling cascades 
associated with H-Ras: Erk, Akt and Jnk. In order to verify if H-Ras could signal on the 
Golgi via an external stimulus, NIH-3T3 cells stably expressing either H-RasWT, SDQCE or 
CDQSE were stimulated with 40 ng/ml of EGF for 10, 30 or 60 minutes. Untransfected 
NIH-3T3 cells were used as a control and stimulated in the same manner. NIH-3T3 cells 
stably expressing the Q61L constitutively active form of H-Ras, CDQSE or SDQCE were 
grown to confluence, lysed and loaded as positive controls. Relative activation levels were 
determined by establishing the phospho-protein signal to total protein signal ratio with the 
Image J densiometry program. 
H-RasWT, CDQSE and NIH-3T3 control cells showed an increase in phospho-Erk activation 
after 10 minutes of EGF stimulation with phosphorylation levels decreasing after 30 and 60 
minutes of stimulation (Figure 7B-D). The levels of activation after 10 minutes of 
stimulation were 3-6 fold greater than that of the control Q61L. Activation levels then fell to 
19 
m 
Figure 1. SDQ resides on the ERGIC, not on the PM. COS-7 expressing the indicated H-Ras constructs were 
costained with anti-H-Ras and anti-ERGIC-53 antibodies. (A) H-RasWT shows colocalization with ERGIC-53 
and is evident on the PM. (B) C184S colocalized with ERGIC-53 and little PM staining. (C) CDQSE shows 
minimal ERGIC-53 colocalization (D) C181S colocalized with ERGIC-53 with very little PM 
localization.(E)SDQCE colocalized with ERGIC-53 with no PM staining evident. Scale bars represent 10 jim, 
Insets show ERGIC region. 
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Figure 2. SDQ accumulates on the Golgi, not on the PM. COS-7 expressing the indicated H-Ras constructs 
were costained with anti-H-Ras and anti-cis-Golgi antibodies(giantin). (A) H-RasWT shows colocalization with 
the giantin and is evident on the PM. (B) C184S colocalized with the giantin and little PM staining. (C) 
CDQSE shows minimal giantin colocalization (D) CI81S colocalized with giantin with very little PM 
localization. (E) SDQCE colocalized with gjantin with no PM staining evident. Scale bars represent 10 jim. 
Insets show cis-Golgi region. 
Figure 3. H-RasWT recruits Raf-1 on PM and endosomes. NIH-3T3 cells stably expressing H-RasWT 
stimulated with 40 ng/ml of EGF and costained with anti-H-Ras and anti-Raf-1 antibodies. (A) No EGF 
stimulation shows no colocalization of H-Ras and Raf-1. (B) 5 minutes of EGF stimulation. Raf-1 is recruited 
to PM and begins to appear on endosomes. (C) 30 minutes of EGF stimulation shows H-Ras and Raf-1 on 
endosomes. (D) 60 minutes of EGF stimulation shows more colocalization on endosomes and not on PM. 
Arrows show areas of Raf-1 recruitment. Scale bars represent 10 jim. 
• 
merge 
Figure 4. CDQSE on endomembranes shows little recruitment of Raf-1. NIH-3T3 cells stably expressing 
CDQSE stimulated with 40 ng/ml of EGF and costained with anti-H-Ras and anti-Raf-1 antibodies. (A-D) 
0,5,30 and 60 minutes of EGF stimulation respectively. Limited colocalization occurs at 30 and 60 minutes. 
Arrows indicate areas of Raf-1 recruitment. Scale bars represent lOjim. 
SDQCE Raf-1 merge 
23 
A 
Figure 5. SDQCE on perinuclear membranes shows strong recruitment of Raf-1 after 30 minutes of 
stimulation. NIH-3T3 cells stably expressing SDQCE stimulated with 40 ng/ml of EGF and costained with 
anti-H-Ras and anti-Raf-1 antibodies. (A-D) 0,5,30 and 60 minutes of EGF stimulation respectively. Strong 
colocalization at 30 minutes with very strong colocalization at 60 minutes. Scale bars represent 10 jim. 
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Figure 6. Percentage of stable cells expressing H-Ras constructs. Cell count of stable NIH-3T3 cell lines 
expressing either H-RasWT, CDQSE or SDQCE. Data show ± SEM of cell counts compiled from 3 separate 
experiments. 
that of the Q61L after 60 minutes of stimulation. SDQCE showed a delayed response to 
EGF stimulation. Phosphorylation levels of Erk increased slightly after 10 minutes, peaked 
after 30 minutes and were sustained after 60 minutes with levels approximately 2.5 fold that 
of Q61L (Figure 7A). SDQCE is able to signal through the Erk cascade via EGF stimulation 
in a temporal manner that differs from H-RasWT or CDQSE. 
Phospho-Akt activation levels are similar to Q61L in all stable cells lines,however the 
timing of peak activation differed. H-RasWT, CDQSE and NIH-3T3 control cells 
demonstrate an increase in phospho-Akt activation after 10 minutes of EGF stimulation with 
a decrease in signal after 30 and 60 minutes (Figure 8B-D). Phospho-Akt activation in 
SDQCE cells displayed a deferred response compared to H-RasWT or CDQSE. The greatest 
activation occurred after 30 minutes of stimulation with little drop off after 60 minutes 
(Figure 8A). The greatest levels of phospho-Akt activation in all stable cell lines were not 
significantly different from Q61L. 
SDQCE, CDQSE and H-RasWT stable cells demonstrated peak levels of phospho-
Jnk activation approximately 2-3 fold greater than the Q61L control (Figure 9A-C). 
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Figure?. Phospho-Erk is phosphorylated more slowly and with a greater duration in SDQ cells. NIH-3T3 
cells stably expressing either H-RasWT, CDQSE or SDQCE were stimulated with 40 ng/ml of EGF for 10, 30 
or 60 minutes, lysed, run on SDS-PAGE, transferred to PVDF and probed with anti-phosph-Erk, anti-Erkl, anti-
H-Ras or anti-Caveolin antibodies. (A) SDQCE expressing cells show increased phosphorylation of Erk after 
30 minutes of stimulation and remain activated after 60 minutes (B-D) CDQSE, H-RasWT and NIH-
3T3untransfected cells (respectively) demonstrate a strong peak of phospho-Erk after 10 minutes of EGF 
stimulation and diminishes after 30 minutes of stimulation. 
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Figure 8. Phospho-Akt activation is distinct in SDQ cells. NIH-3T3 cells stably expressing either H-RasWT, 
CDQSE or SDQCE were stimulated with 40 ng/ml of EGF for 10, 30 or 60 minutes, lysed, run on SDS-PAGE, 
transferred to PVDF and probed with anti-phosph-Akt, anti-Akt, anti-H-Ras or anti-Caveolin antibodies. (A) 
SDQCE expressing cells show strong phospho-Akt signal after 30 minutes of EGF stimulation and continued 
signal after 60 minutes. (B-D) CDQSE, H-RasWT and NIH-3T3 untransfected cells (respectively) demonstrate 
an increase in phospho-Akt signal after 10 minutes of EGF stimulation with a gradual decrease in signal after 30 
and 60 minutes. 
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Figure 9. Phospho-Jnk activation differs among cell types. NIH-3T3 cells stably expressing either H-RasWT, 
CDQSE or SDQCE were stimulated with 40 ng/ml of EGF for 10, 30 or 60 minutes, lysed, run on SDS-PAGE, 
transferred to PVDF and probed with anti-phosph-Jnk, anti-Jnk, anti-H-Ras or anti-Caveolin antibodies. (A) 
SDQCE expressing cells show phospho-Jnk activation after 10 minutes of EGF stimulation and continued 
activation after 30 minutes. (B-D) CDQSE, H-RasWT and NIH-3T3 untransfected cells (respectively) exhibit 
strong phospho-Jnk activation after 10 minutes of EGF stimulation and diminish after 30 minutes. 
H-RasWT, CDQSE and control cells gave a peak of phospho-Jnk activation after 10 
minutes of EGF stimulation and decreased after 30 and 60 minutes (Figure 9B-D). SDQCE 
stable cells displayed a phospho-Jnk activation peak at 10 minutes of EGF stimulation that 
was matched after 30 minutes of stimulation and decreased after 60 minutes of stimulation 
(Figure 9A). 
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Discussion 
Ras's link to cancer has made it one of the most studied signaling molecules in cell 
biology. The very discovery of Ras came from the analysis of carcinoma cells and since then 
the structure and function of Ras has been dissected in order to understand its role in 
oncogenicity. The latest findings that Ras is active on the ER and the Golgi have given new 
light to the function of Ras. Recent evidence has pointed to a role in Ras signaling from the 
Golgi and a possible link to turn orogenesis. 
The data in this thesis have contributed to the overall understanding of Ras signaling 
from the Golgi. The SDQ mutant appears to be an excellent tool to parse the complex 
signaling pathways that occur in the cell. Based on the evidence in this thesis as well as 
other reports, SDQ accumulates in the ERGIC/cis-Golgi region, is palmitoylated and is most 
probably folded in the correct conformation to be able to initiate signal cascades when bound 
to GTP [40, 41]. Indeed, SDQ is unique from the CDQCE, C181S and C184S mutations to 
the tail region of H-Ras in that it does not reach the PM. It seems that the combination of an 
overall change in charge from +1 to -2, coupled with a C181S mutation that eliminates a 
palmitoylation site, is enough to allow SDQ to traffic to the cis-Golgi and go no further. 
More importantly, this thesis as well as other reports have demonstrated that a wild type H-
Ras will accumulate on the cis-Golgi [23, 25, 26, 31, 33 ,39]. This lends credence to idea 
that, in a natural setting, H-Ras will spend a great deal of time on the Golgi and the Golgi 
membrane may provide a suitable platform for signaling. 
Further evidence of H-Ras signaling was demonstrated via recruitment of the Ras 
effector, Raf-1, after stimulation with the growth factor EGF. As illustrated by 
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immunofluorescence, the SDQ Golgi trapped mutant showed a delayed and sustained 
recruitment of Raf-1. This was in contrast to H-Ras wild type which is activated very 
quickly at the PM and shows Raf-1 recruitment. The phenomenon of a delayed recruitment 
of Ras effectors to the Golgi has been verified by other labs in a variety of cell types. The 
idea of the Golgi being a bona fide signaling platform has also been enforced by the findings 
of Golgi specific GEFs for Ras. 
The final piece of evidence in this thesis that lends support to the importance of a 
Golgi initiated signal cascade is established by a temporal difference of activation of 
downstream effectors of Ras. Whereas the cells stably expressing either H-RasWT, H-
RasCDQSE or untransfected cells show an immediate response to EGF stimulation, the SDQ 
mutant shows a delayed and sustained activation of the downstream effectors Erk and Akt. 
This sustained activation of two signaling cascades is significant in greater perpetuation of 
the initial extra cellular stimulation. This may lead the cell to an increased probability of 
transformation or differentiation or an increase in growth or metabolism. Indeed, the 
PI3K/Akt pathway has been implicated in glucose uptake and metabolism, so the notion of a 
molecule that would increase glucose uptake in a time of need does not seem unlikely. Just 
as important, neuronal cells will differentiate and T-cells will grow when the 
Ras/Raf/MEK/Erk pathway is stimulated from a Golgi bound Ras [36]. 
The majority of the focus on Ras signaling looks at its role in cancer. To that end 
many studies have implemented the constitutively active form of Ras to assess its signaling 
parameters [31, 33, 36, 38]. Several studies have used NIH-3T3 cells to stably express either 
the G12V or Q61L active versions of H-Ras with conflicting results [33,38], The 
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Willumsen, etal report [40] used SDQ61L for its transformation focus formation assays 
with poor results. Transforming activity was restored, however, when a myristoylation 
leader sequence was attached to the N-terminus. This indicated that the SDQ protein was 
folded properly and could signal enough to cause transformation. A later study by Zheng 
[41] demonstrated that SDQ could transform and cause focus formation at a rate of 
approximately 30% of H-RasWT61L. The discrepancy was most probably due to a more 
robustly expressing vector having been used by Zheng. Zheng also showed that SDQ61L 
could phosphorylate Erk and Akt on an order close to that of H-RasWT61L . Matallanas 
[38], however, showed that with the KDELr tethered H-RasWT 12V the level of phosho-Erk 
activation was one tenth that of H-RasWT12V and the phospho-Akt was about a third of the 
WT. Matallanas also found no transforming ability when staining for focus formation. The 
difference in outcomes of the SDQ versus the KDELr mutants may be both in the folding and 
orientation of the Ras molecule as well as a biological need for Ras to cycle on and off the 
Golgi. Because the KDELrN193D is a integral membrane protein, it being tethered to the N-
terminus of H-Ras may disrupt the normal conformation of H-Ras, reducing its affinity for 
Raf-1 or PI3K. Matallanas acknowledged that the N193D mutation of KDELr may account 
for its lack of transforming ability. Since the KDELrN193D can not cycle back to the ER, it 
may affect the normal sequence of signaling events. The SDQ mutant is tethered to the 
membrane with the correct conformation and orientation and with a higher amount being in 
the cytosol compared to H-RasWT, it seems to have the ability to cycle on and off the Golgi. 
Indeed, studies have shown that H-Ras is deacylated at the PM and becomes reacylated at the 
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Golgi. The acylation cycle appears to be essential for proper membrane localization of H-
Ras as well as promoting a signaling cascade [25,26], 
These data in this thesis have demonstrated that SDQ is an excellent tool for 
examining Golgi based signaling. While the most documented pathways have been studied, 
there is still a great deal of work to be done where Golgi signaling is considered. 
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